Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials. (nature.com)

Authors: Ezzedine K … Pandya AG Journal: Nature Medicine Published: 2026-11-02 DOI: https://doi.org/10.1038/s41591-026-04739-2